
Histogenics Corporation (HSGX) shares rallied strongly today. The stock traded nearly 32 million shares as of 2 PM EST, and could potentially exceed 40 million shares by the close. As of the time this content was created, the stock was up over 36%. It is not immediately clear why shares are moving today, but I suspect it has something to do with possible FDA clearance of Neocart, which is HSGX’s flagship product. There are other possible reasons as well. Here’s a recap.